PRONORVAL Trademark

Trademark Overview

On Tuesday, January 20, 2004, a trademark application was filed for PRONORVAL with the United States Patent and Trademark Office. The USPTO has given the PRONORVAL trademark a serial number of 79001136. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, October 27, 2020. This trademark is owned by BIOFARMA. The PRONORVAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cardiovascular disease, anti-athero thrombotic pharmaceutical preparations; pharmaceutical preparations for diseases of the central nervous system, antidepressants
pronorval

General Information

Serial Number79001136
Word MarkPRONORVAL
Filing DateTuesday, January 20, 2004
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, October 27, 2020
Registration Number3011524
Registration DateTuesday, November 1, 2005
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cardiovascular disease, anti-athero thrombotic pharmaceutical preparations; pharmaceutical preparations for diseases of the central nervous system, antidepressants

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 8, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOFARMA
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFR
Party NameBIOFARMA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFR
Party NameBIOFARMA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFR

Trademark Events

Event DateEvent Description
Tuesday, April 12, 2022UNDELIVERABLE MAIL - NO ACTION TAKEN
Sunday, May 16, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, May 16, 2021DEATH OF INTERNATIONAL REGISTRATION
Thursday, March 6, 2014TOTAL INVALIDATION PROCESSED BY THE IB
Monday, January 13, 2014TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, February 8, 2013TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 8, 2012CANCELLED SECTION 71
Sunday, December 4, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, November 11, 2010INTERNATIONAL REGISTRATION RENEWED
Friday, August 31, 2007FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 14, 2006FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 14, 2006FINAL DISPOSITION PROCESSED
Monday, June 19, 2006FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 1, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, August 9, 2005PUBLISHED FOR OPPOSITION
Wednesday, July 20, 2005NOTICE OF PUBLICATION
Tuesday, April 26, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 22, 2005ASSIGNED TO LIE
Monday, April 18, 2005EXAMINERS AMENDMENT MAILED
Monday, April 18, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 18, 2005EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 29, 2005AMENDMENT FROM APPLICANT ENTERED
Monday, March 14, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 14, 2005PAPER RECEIVED
Thursday, October 7, 2004REFUSAL PROCESSED BY IB
Wednesday, September 8, 2004NON-FINAL ACTION MAILED
Monday, August 9, 2004ASSIGNED TO EXAMINER
Wednesday, March 17, 2004NEW APPLICATION ENTERED IN TRAM
Friday, March 12, 2004SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

pronorval pharmaceutical preparations central diseases system antidepressants thrombotic nervous anti prevention